Analyst Ratings for Avidity Biosciences (RNA)
RNA Rating Summary
RNA Price Target Summary
- Highest: $96.00 (Cantor Fitzgerald)
- Lowest: $55.00 (Goldman Sachs)
- Average: $71.58
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$71.58 (+383%)
* Over Last 12-Mos
Rating Score: 4.8 / 10
Percentile Rank: 48%
Avg. $ Target:
$71.58 (+383%)
* Over Last 12-Mos
Rating Score: 4.8 / 10
Percentile Rank: 48%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/18/2025 | Evercore ISI | Gavin Clark-Gartner | Downgrade | In Line (Outperform) |
72.00 (65.00) |
71.97 (14.82) |
-79.41% | Details |
| 11/7/2025 | Chardan | Keay Nakae | Downgrade | Neutral (Buy) |
72.00 (75.00) |
69.80 (14.82) |
-78.77% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
